Odyssean LLC’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.02M Buy
155,654
+70,157
+82% +$1.98M 0.46% 99
2026
Q2
$2.64M Buy
+85,497
New +$2.11M 0.43% 95

Other funds holding RCUS

Odyssean LLC's RCUS Position: Q3 2026 in Review

Odyssean LLC increased its Arcus Biosciences (RCUS) stake by 82% in Q3 2026, buying an estimated $1.98M and bringing the position to 155,654 shares worth $4.02M. The position accounts for 0.46% of the portfolio, ranked #99.

Odyssean LLC first reported a position in RCUS in Q2 2026 and has held it in 2 quarters since. 244 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.

  • Odyssean LLC held 155,654 shares of Arcus Biosciences worth $4.02M as of Q3 2026.
  • Odyssean LLC bought 70,157 Arcus Biosciences shares in Q3 2026, an estimated $1.98M.
  • Arcus Biosciences made up 0.46% of Odyssean LLC's portfolio in Q3 2026, its #99 holding.
  • Odyssean LLC first reported a position in Arcus Biosciences in Q2 2026 and has held it in 2 quarters since.
  • 244 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.

Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.